Skip to content

Drug interactions

Imatinib + Trastuzumab deruxtecan

Severity: Moderate

Imatinib and Trastuzumab deruxtecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can cause neutropenia and other myelosuppression, so combined use may increase infection risk. Trastuzumab deruxtecan additionally causes interstitial lung disease and cardiac toxicity.

What this interaction means in plain words

Imatinib and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.

Evidence level: Low

Why it happens

Additive myelosuppression through different pharmacodynamic mechanisms.

What to do

Monitor complete blood counts regularly and manage neutropenia with dose interruption or reduction per labeling. Counsel patients to report fever or respiratory symptoms promptly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Trastuzumab deruxtecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Trastuzumab deruxtecan?

MediHelp rates the interaction as moderate. Imatinib and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can cause neutropenia and other myelosuppression, so combined use may increase infection risk. Trastuzumab deruxtecan additionally causes interstitial lung disease and cardiac toxicity.

How serious is the interaction between Imatinib and Trastuzumab deruxtecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts regularly and manage neutropenia with dose interruption or reduction per labeling. Counsel patients to report fever or respiratory symptoms promptly.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in